Search clinical trials for: Bicalutamide

Total 189 results

University of Wisconsin, Madison
Pfizer

Terminated

CP-675,206 in Combination With Short Term Androgen Deprivation in Patients With Stage D0 Prostate Cancer

Prostate Cancer

United States
Fox Chase Cancer Center

Completed

Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients (BIMET-1)

Cancer of Prostate

United States
University of L'Aquila

Completed

Survival Outcomes and Tumor Molecular Profile Following Bicalutamide Neoadjuvant Therapy

Prostate Cancer

Italy
AstraZeneca

No longer available

Casodex 150-mg Compassionate Use Trial for Subjects With Prostate Cancer

Adenocarcinoma of the Prostate
Alessa Therapeutics Inc.

Completed

A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate Cancer (Biolen-PC)

Lower Urinary Tract Symptoms | Prostate Adenocarcinoma

United States, Australia, New Zealand
Royal College of Surgeons, Ireland
University College Dublin; University of Oxford; University of Liverpool; University...

Not yet recruiting

The RolE oF Androgen Excess in MUscle Energy MetaboLism in Women With PolyCystic Ovary Syndrome (REFUEL PCOS) Study 2 (REFUEL PCOS)

Polycystic Ovary Syndrome | Metabolic Disease | Androgen Excess

Ireland
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Withdrawn

Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer

Prostate Cancer
Sandoz

Completed

Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions

Prostate Cancer | Hirsutism
Sandoz

Completed

Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions

Prostate Cancer | Hirsutism
Astellas Pharma Inc
Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Completed

A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer

Prostatic Neoplasms

United States, Belgium, Canada, Denmark, France, Germany, Romania, United Kingdom
Universitaire Ziekenhuizen KU Leuven
Eli Lilly and Company; Kom Op Tegen Kanker; Teva Pharma

Recruiting

Bicalutamide and Abemaciclib in Inoperable or Metastatic Androgen Receptor-positive Triple-negative Breast Cancer (ABBICAR)

Triple Negative Breast Neoplasms

Belgium
CHU de Quebec-Universite Laval
GlaxoSmithKline

Completed

Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy

Lower Urinary Tract Symptoms | Erectile Dysfunction | Prostate Cancer

Canada
Alessa Therapeutics Inc.
National Cancer Institute (NCI)

Recruiting

Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer (BiolenRT)

Prostate Adenocarcinoma

United States
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology; Southwest Oncology Group

Completed

Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy

Prostate Cancer

United States, Canada
University of California, San Francisco
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Bicalutamide Therapy in Young Women With NAFLD and PCOS

PCOS | NAFLD

United States
University of Florida

Withdrawn

Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection

COVID-19
Sidney Kimmel Comprehensive Cancer Center at Johns...

Withdrawn

Trial to Promote Recovery From COVID-19 With Endocrine Therapy (RECOVER)

COVID-19 | SARS-CoV 2

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); AstraZeneca

Completed

Bicalutamide in Treating Patients With Metastatic Breast Cancer

Breast Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States
Tampere University

Completed

Casodex/Zoladex Biomarkers in Localised Prostate Cancer

Prostate Cancer

Finland
AstraZeneca

Completed

CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer

Prostatic Neoplasms

United States
Sun Yat-sen University

Terminated

Bicalutamide in Treatment of Androgen Receptor (AR) Positive Metastatic Triple Negative Breast Cancer (SYSUCC-007)

Metastatic Triple Negative Breast Cancer

China
Sandy Srinivas
Wyeth is now a wholly owned subsidiary of Pfizer; American Society of Clinical... and other collaborators

Terminated

Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer

Prostatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate Cancer

United States
European Organisation for Research and Treatment...

Terminated

Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer

Prostate Cancer

Germany
Southwest Oncology Group
National Cancer Institute (NCI); European Organisation for Research and Treatment... and other collaborators

Completed

SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer

Prostate Cancer

Canada
Kremers Urban Development Company
Watson Laboratories, Inc.

Completed

Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet in Healthy Subjects Under Fasting Conditions

Bioequivalency

Canada
Institut Paoli-Calmettes
Novartis

Terminated

Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate Cancer (NCMPC-BKM)

Non Castrate Metastatic Prostate Cancer

France
University of Alabama at Birmingham
National Cancer Institute (NCI)

Completed

Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy

Prostate Cancer

United States
Speciality European Pharma Limited

Completed

Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer

Prostate Cancer
European Organisation for Research and Treatment...

Completed

Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer

Prostate Cancer

Belgium, Italy, France, Netherlands, United Kingdom, Poland, Ireland, Spain, Cyprus, Czech Republic, Luxembourg
Aragon Pharmaceuticals, Inc.

Active, not recruiting

An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS

Prostatic Neoplasms

United States, France, Poland, Taiwan, Ukraine, United Kingdom, China, Belgium, Germany, Spain, Israel, Mexico, Malaysia, Romania, Turkey, Canada, Netherlands, Korea, Republic of, Brazil, Russian Federation, Argentina, Sweden, Czechia
CHU de Quebec-Universite Laval
Cancer Research Society

Withdrawn

A Canadian Trial of Bicalutamide in Patients Receiving Maintenance Avelumab for Metastatic Urothelial Cancer. (CANUCK-01)

Metastatic Urothelial Carcinoma

Canada
Radiation Therapy Oncology Group
National Cancer Institute (NCI); NCIC Clinical Trials Group

Completed

Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer

Prostate Cancer

Canada
Swiss Group for Clinical Cancer Research

Completed

Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer

Prostate Cancer

Switzerland
GlaxoSmithKline

Completed

Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy

Neoplasms, Prostate

United States, Canada
University of Kansas Medical Center

Completed

Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer

Prostate Cancer

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer

Prostate Cancer

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Withdrawn

Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer

Prostate Cancer
Abdenour Nabid
AstraZeneca

Active, not recruiting

Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone (PCS III)

Prostate Cancer

Canada
Tianjin Medical University Cancer Institute and...
Peking University First Hospital; The Affiliated Nanjing Drum Tower Hospital... and other collaborators

Unknown

Cryoablation Therapy or Radiotherapy Therapy for Stage III Prostate Cancer (CRYO-PCA-III)

Stage III Prostate Cancer

China
University of Nebraska
National Cancer Institute (NCI)

Completed

Intensity-Modulated Radiation Therapy, Docetaxel, and Hormone Therapy in Treating Patients With High-Risk Locally Advanced Prostate Cancer With Pelvic Lymph Node Metastasis

Prostate Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Withdrawn

A Phase 2 Study of Bicalutamide Plus Finasteride in Men With MRI Detectable Prostate Nodules Undergoing Active Surveillance

Detectable Prostate Nodules

United States
National Cancer Institute (NCI)

Terminated

Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer

Recurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer

United States
Virginia Mason Hospital/Medical Center

Unknown

Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Prostate Cancer

United States
Marco Lorenzo Bonu
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Recruiting

SRT Versus SRT+ADT in Prostate Cancer (SPA)

Prostate Cancer

Italy
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer

Prostate Cancer

France
Mayo Clinic
National Cancer Institute (NCI)

Completed

Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy

Prostate Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Terminated

Camostat With Bicalutamide for COVID-19 (COMBO)

Coronavirus Infection | Covid19 | SARS-CoV Infection

United States
Benaroya Research Institute
Genentech, Inc.

Completed

Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancer

Prostate Cancer

United States
Wirral University Teaching Hospital NHS Trust
AstraZeneca

Completed

Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer

Prostatic Neoplasms

United Kingdom

Search clinical trials for: Bicalutamide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cameroon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations